Get the Stockscreener App
2.28
7.32%
-0.18
After Hours:
2.28
Macrogenics Inc Stock (MGNX) Latest News
Macrogenics Stock Hits 52-Week Low at $2.31 Amid Sharp Decline By Investing.com - Investing.com South Africa
MACROGENICS Earnings Preview: Recent $MGNX Insider Trading, Hedge Fund Activity, and More - Nasdaq
MacroGenics, Inc. (MGNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Shareholders that lost money on MacroGenics, Inc. (MGNX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Sept. 24th Deadline Alert: Investors Who Lost More Than $100,000 With MacroGenics, Inc. (NASDAQ:MGNX) Shares Should Contact the Shareholders Foundation - ACCESS Newswire
MacroGenics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by MacroGenics, Inc. (MGNX) - ACCESS Newswire
MacroGenics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsMGNX - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate MacroGenics, Inc. (MGNX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
MacroGenics, Inc. (NASDAQ:MGNX) Not Doing Enough For Some Investors As Its Shares Slump 26% - Simply Wall St
Lost Money on MacroGenics, Inc. (MGNX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of an Investigation into MacroGenics, Inc. (MGNX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMGNX - ACCESS Newswire
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
MacroGenics: Stacking Up A Lot Of Headwinds... But It's Fallen Too Far - Seeking Alpha
MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire
How Will MacroGenics Address Investors at Three Key Healthcare Conferences? - StockTitan
MacroGenics CEO departure date extended amid search for successor By Investing.com - Investing.com Australia
MacroGenics (MGNX) to Release Earnings on Thursday - Defense World
MacroGenics, Inc. to Host Earnings Call - ACCESS Newswire
Shareholders of MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights – MGNX - ACCESS Newswire
MacroGenics CEO departure date extended amid search for successor - Investing.com
MacroGenics Extends CEO’s Separation Agreement - TipRanks
MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of MacroGenics, Inc. to Contact the Firm Today! - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Shareholders that lost money on MacroGenics, Inc.(MGNX) should contact Levi & Korsinsky about pending Class ActionMGNX - ACCESS Newswire
Shareholders that Lost Money on MacroGenics, Inc. (MGNX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investor Network: MacroGenics, Inc. to Host Earnings Call - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire
MacroGenics, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsMGNX - ACCESS Newswire
Macrogenics VP Beth Smith sells $1,082 in common stock By Investing.com - Investing.com South Africa
Macrogenics VP Beth Smith sells $1,082 in common stock - Investing.com
Macrogenics Stock Hits 52-Week Low at $2.91 Amid Sharp Decline - MSN
Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
The Curious Case of MacroGenics: A Cautionary Tale for Investors - Mi Valle
The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable - Yahoo Finance
MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug TrialHagens Berman - ACCESS Newswire
SG Americas Securities LLC Purchases 17,577 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Cancer Index takes hit in 2024 amid regulatory setbacks, failures - BioWorld Online
MGNX stock plunges to 52-week low, hitting $2.37 - Investing.com
Macrogenics Inc (MGNX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Further weakness as MacroGenics (NASDAQ:MGNX) drops 11% this week, taking one-year losses to 86% - Simply Wall St
Recent Insider Activity Suggests Potential Gains for Macrogenics Inc (MGNX) - Knox Daily
Ratio Revelations: Macrogenics Inc (MGNX)’s Financial Metrics in the Spotlight - The Dwinnex
Lost Money on MacroGenics, Inc. (MGNX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Can Macrogenics Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Macrogenics Inc (MGNX) Stock Observes -39.73% 200-Day Moving Average - The News Heater
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, - GlobeNewswire
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and MaplebearJohnson - The Bakersfield Californian
Holdings of Macrogenics Inc (MGNX) are aligned with the stars - SETE News
Macrogenics Inc (MGNX) deserves closer scrutiny - US Post News
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc.(MGNX) Shareholders - ACCESS Newswire
Ratio Review: Analyzing Macrogenics Inc (MGNX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. LawsuitMGNX - ACCESS Newswire
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Rating of “Hold” from Brokerages - Defense World
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):